title: Angiotensin II: a new approach for refractory shock management?
abstract: Patients with distributive shock still have a high mortality rate and remain an important issue for intensivists. Management of catecholamine-resistant shock in these patients poses a challenging problem. Despite significant advances in the knowledge of its pathophysiology, all innovative therapeutic approaches and interventions have failed to improve outcome. In the previous issue of Critical Care, Chawla and colleagues explored the impact of angiotensin II administration in patients with persistent hypotension despite adapted hemodynamic resuscitation. The authors demonstrate that, in case of distributive shock, angiotensin II is an effective vasopressor therapy. Its impact on outcome and adverse effects still needs to be further explored.
authors: Antoine
authors: A
authors: Kimmoun
authors: Bruno
authors: B
authors: Levy
mesh_terms: D000804:Angiotensin II / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000627:therapeutic use*; D012772:Shock, Septic / Q000188:drug therapy*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
chemical_list: D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D009638:Norepinephrine
references: Intensive Care Med. 2010 Dec;36(12):2019-29
references: 20862451
references: Crit Care Med. 2004 Jan;32(1):21-30
references: 14707556
references: Crit Care Med. 1999 May;27(5):913-22
references: 10362413
references: Methods Find Exp Clin Pharmacol. 2006 Jun;28(5):307-13
references: 16845448
references: N Engl J Med. 2008 Feb 28;358(9):877-87
references: 18305265
references: Intensive Care Med. 2009 Aug;35(8):1471-8
references: 19529910
references: Crit Care. 2014;18(5):534
references: 25286986
references: Intensive Care Med. 2012 Jun;38(6):950-8
references: 22527060
references: Am J Crit Care. 2013 Jan;22(1):22-32
references: 23283085
references: JAMA. 2014 Apr 2;311(13):1308-16
references: 24638143
references: Chest. 2014 Jun;145(6):1407-18
references: 24889440
references: Crit Care Med. 2014 Jul;42(7):e525-33
references: 24674922
references: Crit Care. 2013;17(4):R130
references: 23844607